Approval · Notice of Compliance 35601 · 2025
GLICLAZIDE: Notice of Compliance 35601
Issued June 30, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 35601
- Date
- June 30, 2025
- Company
- Sanis Health Inc.Brampton, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Admin
- Reason
- Administrative: Update to labelling (to match Licensor)
- Canadian reference product
- DIAMICRON (Servier Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| GLICLAZIDE | Not yet assigned | — |
Medicinal ingredients
- GLICLAZIDE 80 MG per TAB